80 related articles for article (PubMed ID: 17568385)
1. A recombinant 19 kDa Plasmodium berghei merozoite surface protein 1 formulated with alum induces protective immune response in mice.
Wan Omar A; Roslaini AM; Ngah ZU; Azahari AA; Zahedi M; Baharudin O
Trop Biomed; 2007 Jun; 24(1):119-26. PubMed ID: 17568385
[TBL] [Abstract][Full Text] [Related]
2. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
[TBL] [Abstract][Full Text] [Related]
3. Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.
Near KA; Stowers AW; Jankovic D; Kaslow DC
Infect Immun; 2002 Feb; 70(2):692-701. PubMed ID: 11796601
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of C3d on the immunogenicity of gene gun vaccines encoding Plasmodium falciparum and Plasmodium berghei MSP1(42).
Weiss R; Gabler M; Jacobs T; Gilberger TW; Thalhamer J; Scheiblhofer S
Vaccine; 2010 Jun; 28(28):4515-22. PubMed ID: 20438877
[TBL] [Abstract][Full Text] [Related]
5. A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice.
Hirunpetcharat C; Mahakunkijcharoen Y; Jeamwattanalert P; Kittigul L; Mahannop P; Pichyangkul S
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):252-9. PubMed ID: 22053595
[TBL] [Abstract][Full Text] [Related]
6. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].
Cao Y; Zhang DM; Pan WQ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293
[TBL] [Abstract][Full Text] [Related]
7. CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based Montanides.
Hirunpetcharat C; Wipasa J; Sakkhachornphop S; Nitkumhan T; Zheng YZ; Pichyangkul S; Krieg AM; Walsh DS; Heppner DG; Good MF
Vaccine; 2003 Jun; 21(21-22):2923-32. PubMed ID: 12798636
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
[TBL] [Abstract][Full Text] [Related]
9. A novel adjuvant, the mixture of alum and naltrexone, augments vaccine-induced immunity against Plasmodium berghei.
Shahabi S; Azizi H; Mazloomi E; Tappeh KH; Seyedi S; Mohammadzadeh H
Immunol Invest; 2014; 43(7):653-66. PubMed ID: 25020077
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium berghei merozoite surface protein-9: immunogenicity and protective efficacy using a homologous challenge model.
Lopera-Mesa TM; Kushwaha A; Mohmmed A; Chauhan VS
Vaccine; 2008 Mar; 26(10):1335-43. PubMed ID: 18272263
[TBL] [Abstract][Full Text] [Related]
11. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
Burns JM; Flaherty PR; Nanavati P; Weidanz WP
Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
[TBL] [Abstract][Full Text] [Related]
12. Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.
Pichyangkul S; Gettayacamin M; Miller RS; Lyon JA; Angov E; Tongtawe P; Ruble DL; Heppner DG; Kester KE; Ballou WR; Diggs CL; Voss G; Cohen JD; Walsh DS
Vaccine; 2004 Sep; 22(29-30):3831-40. PubMed ID: 15364429
[TBL] [Abstract][Full Text] [Related]
13. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
[TBL] [Abstract][Full Text] [Related]
14. [Study on Ficolin-A against infection of Plasmodium berghei in mouse model].
Xiang T; Xiang T; Liu G; Dai WA; Li ZQ; Chen F
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Feb; 32(1):42-5. PubMed ID: 24822364
[TBL] [Abstract][Full Text] [Related]
15. A blood stage fraction of Plasmodium berghei induces protective and long lasting immune response in BALB/c mice.
Bagai U; Pawar A
Parasitol Int; 2013 Jun; 62(3):329-36. PubMed ID: 23085043
[TBL] [Abstract][Full Text] [Related]
16. Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery.
Goyal AK; Khatri K; Mishra N; Mehta A; Vaidya B; Tiwari S; Paliwal R; Paliwal S; Vyas SP
J Biomater Appl; 2009 Jul; 24(1):65-84. PubMed ID: 19386666
[TBL] [Abstract][Full Text] [Related]
17. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.
Bargieri DY; Rosa DS; Braga CJ; Carvalho BO; Costa FT; EspĂndola NM; Vaz AJ; Soares IS; Ferreira LC; Rodrigues MM
Vaccine; 2008 Nov; 26(48):6132-42. PubMed ID: 18804504
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium berghei circumsporozoite protein encapsulated in oligomannose-coated liposomes confers protection against sporozoite infection in mice.
Terkawi MA; Kuroda Y; Fukumoto S; Tanaka S; Kojima N; Nishikawa Y
Malar J; 2014 Nov; 13():426. PubMed ID: 25373617
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants.
Sachdeva S; Mohmmed A; Dasaradhi PV; Crabb BS; Katyal A; Malhotra P; Chauhan VS
Vaccine; 2006 Mar; 24(12):2007-16. PubMed ID: 16377036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]